1/15
11:52 am
prax
Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus [Yahoo! Finance]
Low
Report
Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus [Yahoo! Finance]
1/14
04:31 am
prax
Is It Too Late To Reassess Praxis Precision Medicines (PRAX) After Its 1-Year Surge? [Yahoo! Finance]
Medium
Report
Is It Too Late To Reassess Praxis Precision Medicines (PRAX) After Its 1-Year Surge? [Yahoo! Finance]
1/13
04:30 pm
prax
Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
Medium
Report
Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy
1/12
09:02 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Wedbush from $83.00 to $95.00. They now have an "underperform" rating on the stock.
Medium
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its price target raised by analysts at Wedbush from $83.00 to $95.00. They now have an "underperform" rating on the stock.
1/12
08:27 am
prax
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress [Yahoo! Finance]
Medium
Report
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress [Yahoo! Finance]
1/12
08:00 am
prax
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
Medium
Report
Praxis Precision Medicines Enters Its Next Chapter Following a Pivotal Year of Progress
1/11
01:26 am
prax
Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX) [Yahoo! Finance]
Medium
Report
Needham Analyst Keeps a Buy Rating on Praxis Precision Medicines, Inc. (PRAX) [Yahoo! Finance]
1/9
04:01 pm
prax
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1/8
04:45 pm
prax
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
Low
Report
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
1/7
01:33 pm
prax
Praxis Precision Medicines (PRAX) Valuation Check After A Strong 90 Day Share Price Run [Yahoo! Finance]
Low
Report
Praxis Precision Medicines (PRAX) Valuation Check After A Strong 90 Day Share Price Run [Yahoo! Finance]
1/6
11:15 pm
prax
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
Medium
Report
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering
1/6
04:03 pm
prax
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
High
Report
Praxis Precision Medicines, Inc. Announces Proposed Public Offering
1/5
08:42 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC.
1/2
02:01 pm
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Cowen Inc.
12/31
08:16 am
prax
Praxis: Priced For Perfection Heading Into 2026 [Seeking Alpha]
Low
Report
Praxis: Priced For Perfection Heading Into 2026 [Seeking Alpha]
12/30
11:07 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "conviction-buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "conviction-buy" rating reaffirmed by analysts at Citigroup Inc..
12/30
08:12 am
prax
Praxis Precision granted Breakthrough Therapy designation for Ulixacaltamide [Yahoo! Finance]
Low
Report
Praxis Precision granted Breakthrough Therapy designation for Ulixacaltamide [Yahoo! Finance]
12/30
08:02 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
12/29
07:51 pm
prax
Why Praxis Precision Medicines Stock Popped Today [Yahoo! Finance]
Low
Report
Why Praxis Precision Medicines Stock Popped Today [Yahoo! Finance]
12/29
03:52 pm
prax
Praxis Precision Heading for 'Exciting' 2026, Truist Says [Yahoo! Finance]
Low
Report
Praxis Precision Heading for 'Exciting' 2026, Truist Says [Yahoo! Finance]
12/29
03:04 pm
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at Guggenheim.
12/29
08:12 am
prax
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor [Yahoo! Finance]
Low
Report
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor [Yahoo! Finance]
12/29
08:00 am
prax
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
High
Report
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
12/29
07:39 am
prax
Stocks making the biggest moves premarket: DigitalBridge, Praxis Precision Medicines, Coupang & more [CNBC]
High
Report
Stocks making the biggest moves premarket: DigitalBridge, Praxis Precision Medicines, Coupang & more [CNBC]
12/29
07:13 am
prax
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at BTIG Research.
High
Report
Praxis Precision Medicines (NASDAQ:PRAX) had its "buy" rating reaffirmed by analysts at BTIG Research.